BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24950197)

  • 1. Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.
    Kuppusamy H; Ogmundsdottir HM; Baigorri E; Warkentin A; Steingrimsdottir H; Haraldsdottir V; Mant MJ; Mackey J; Johnston JB; Adamia S; Belch AR; Pilarski LM
    PLoS One; 2014; 9(6):e100691. PubMed ID: 24950197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
    Adamia S; Reichert AA; Kuppusamy H; Kriangkum J; Ghosh A; Hodges JJ; Pilarski PM; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Blood; 2008 Dec; 112(13):5111-21. PubMed ID: 18815290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia.
    Adamia S; Treon SP; Reiman T; Tournilhac O; McQuarrie C; Mant MJ; Belch AR; Pilarski LM
    Clin Lymphoma; 2005 Mar; 5(4):253-6. PubMed ID: 15794859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
    Adamia S; Reiman T; Crainie M; Mant MJ; Belch AR; Pilarski LM
    Blood; 2005 Jun; 105(12):4836-44. PubMed ID: 15731173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic abnormalities in Waldenström's macroglobulinemia.
    Adamia S; Pilarski PM; Belch AR; Pilarski LM
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):30-2. PubMed ID: 19362966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
    Kriangkum J; Warkentin A; Belch AR; Pilarski LM
    PLoS One; 2013; 8(1):e53469. PubMed ID: 23301075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
    Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
    Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
    Xu L; Hunter ZR; Yang G; Zhou Y; Cao Y; Liu X; Morra E; Trojani A; Greco A; Arcaini L; Varettoni M; Brown JR; Tai YT; Anderson KC; Munshi NC; Patterson CJ; Manning RJ; Tripsas CK; Lindeman NI; Treon SP
    Blood; 2013 Mar; 121(11):2051-8. PubMed ID: 23321251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial paraproteinemia: hyper-responsive B-cells as endophenotype.
    Ögmundsdóttir HM; Steingrímsdóttir H; Haraldsdóttir V
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):82-4. PubMed ID: 21454198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    McMaster ML; Caporaso N
    Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
    Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia.
    Adamia S; Crainie M; Kriangkum J; Mant MJ; Belch AR; Pilarski LM
    Semin Oncol; 2003 Apr; 30(2):165-8. PubMed ID: 12720129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.
    Ghosh A; Kuppusamy H; Pilarski LM
    J Biol Chem; 2009 Jul; 284(28):18840-50. PubMed ID: 19451652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
    Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M
    Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
    McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.